{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,2]],"date-time":"2026-06-02T04:57:00Z","timestamp":1780376220402,"version":"3.54.1"},"reference-count":74,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["surgpath.theclinics.com","clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Surgical Pathology Clinics"],"published-print":{"date-parts":[[2025,6]]},"DOI":"10.1016\/j.path.2024.11.001","type":"journal-article","created":{"date-parts":[[2024,12,3]],"date-time":"2024-12-03T12:34:42Z","timestamp":1733229282000},"page":"341-358","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"title":["Pediatric Pathology"],"prefix":"10.1016","volume":"18","author":[{"given":"Maria Laura","family":"Galluzzo Mutti","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jennifer","family":"Picarsic","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"2","key":"10.1016\/j.path.2024.11.001_bib1","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1002\/pbc.24367","article-title":"Langerhans cell histiocytosis (LCH): guidelines for diagnosis, clinical work-up, and treatment for patients till the age of 18 years","volume":"60","author":"Haupt","year":"2013","journal-title":"Pediatr Blood Cancer"},{"issue":"1","key":"10.1016\/j.path.2024.11.001_bib2","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1038\/s41572-021-00307-9","article-title":"Histiocytic disorders","volume":"7","author":"McClain","year":"2021","journal-title":"Nat Rev Dis Primers"},{"issue":"14","key":"10.1016\/j.path.2024.11.001_bib3","doi-asserted-by":"crossref","first-page":"2416","DOI":"10.1002\/cncr.35301","article-title":"Langerhans cell histiocytosis: NACHO update on progress, chaos, and opportunity on the path to rational cures","volume":"130","author":"Bielamowicz","year":"2024","journal-title":"Cancer"},{"issue":"2","key":"10.1016\/j.path.2024.11.001_bib4","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1002\/pbc.20425","article-title":"Risk factors for diabetes insipidus in langerhans cell histiocytosis","volume":"46","author":"Grois","year":"2006","journal-title":"Pediatr Blood Cancer"},{"key":"10.1016\/j.path.2024.11.001_bib5","series-title":"WHO classification of tumours editorial board. Haematolymphoid tumours","article-title":"Langerhans cell histiocytosis","author":"Picarsic","year":"2024"},{"issue":"7","key":"10.1016\/j.path.2024.11.001_bib6","doi-asserted-by":"crossref","first-page":"1703","DOI":"10.1038\/s41375-022-01613-1","article-title":"The 5th edition of the world Health organization classification of haematolymphoid tumours: myeloid and histiocytic\/dendritic neoplasms","volume":"36","author":"Khoury","year":"2022","journal-title":"Leukemia"},{"key":"10.1016\/j.path.2024.11.001_bib7","series-title":"WHO classification of tumours editorial board. Paediatric tumours [internet]","article-title":"Langerhans cell histiocytosis and related disorders","author":"Picarsic","year":"2022"},{"issue":"5","key":"10.1016\/j.path.2024.11.001_bib8","doi-asserted-by":"crossref","first-page":"990","DOI":"10.1016\/j.jpeds.2014.07.063","article-title":"Differentiating skin-limited and multisystem Langerhans cell histiocytosis","volume":"165","author":"Simko","year":"2014","journal-title":"J Pediatr"},{"issue":"1","key":"10.1016\/j.path.2024.11.001_bib9","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1097\/DAD.0000000000001255","article-title":"Langerhans cell histiocytoma: a Benign histiocytic neoplasm of diverse lines of terminal differentiation","volume":"41","author":"Dupeux","year":"2019","journal-title":"Am J Dermatopathol"},{"issue":"6","key":"10.1016\/j.path.2024.11.001_bib10","doi-asserted-by":"crossref","first-page":"802","DOI":"10.1002\/pbc.20362","article-title":"Langerhans cell histiocytosis in neonates","volume":"45","author":"Minkov","year":"2005","journal-title":"Pediatr Blood Cancer"},{"issue":"4","key":"10.1016\/j.path.2024.11.001_bib11","first-page":"1137","article-title":"Dabrafenib and trametinib in Langerhans cell histiocytosis and other histiocytic disorders","volume":"109","author":"Cournoyer","year":"2024","journal-title":"Haematologica"},{"issue":"25","key":"10.1016\/j.path.2024.11.001_bib12","doi-asserted-by":"crossref","first-page":"3023","DOI":"10.1200\/JCO.2015.65.9508","article-title":"BRAF mutation correlates with high-risk langerhans cell histiocytosis and increased resistance to first-line therapy","volume":"34","author":"Heritier","year":"2016","journal-title":"J Clin Oncol"},{"issue":"4","key":"10.1016\/j.path.2024.11.001_bib13","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1084\/jem.20130977","article-title":"BRAF-V600E expression in precursor versus differentiated dendritic cells defines clinically distinct LCH risk groups","volume":"211","author":"Berres","year":"2014","journal-title":"J Exp Med"},{"issue":"1","key":"10.1016\/j.path.2024.11.001_bib14","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1182\/blood-2014-12-569301","article-title":"How I treat Langerhans cell histiocytosis","volume":"126","author":"Allen","year":"2015","journal-title":"Blood"},{"issue":"8","key":"10.1016\/j.path.2024.11.001_bib15","doi-asserted-by":"crossref","first-page":"4557","DOI":"10.4049\/jimmunol.0902336","article-title":"Cell-specific gene expression in Langerhans cell histiocytosis lesions reveals a distinct profile compared with epidermal Langerhans cells","volume":"184","author":"Allen","year":"2010","journal-title":"J Immunol"},{"issue":"9","key":"10.1016\/j.path.2024.11.001_bib16","doi-asserted-by":"crossref","first-page":"856","DOI":"10.1056\/NEJMra1607548","article-title":"Langerhans-cell histiocytosis","volume":"379","author":"Allen","year":"2018","journal-title":"N Engl J Med"},{"issue":"5","key":"10.1016\/j.path.2024.11.001_bib17","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1016\/j.hoc.2015.06.004","article-title":"Genomic alterations in langerhans cell histiocytosis","volume":"29","author":"Rollins","year":"2015","journal-title":"Hematol Oncol Clin North Am"},{"issue":"11","key":"10.1016\/j.path.2024.11.001_bib18","doi-asserted-by":"crossref","first-page":"1919","DOI":"10.1182\/blood-2010-04-279083","article-title":"Recurrent BRAF mutations in Langerhans cell histiocytosis","volume":"116","author":"Badalian-Very","year":"2010","journal-title":"Blood"},{"issue":"3","key":"10.1016\/j.path.2024.11.001_bib19","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1111\/bjh.14695","article-title":"Circulating cell-free BRAF(V600E) as a biomarker in children with Langerhans cell histiocytosis","volume":"178","author":"Heritier","year":"2017","journal-title":"Br J Haematol"},{"issue":"9","key":"10.1016\/j.path.2024.11.001_bib20","doi-asserted-by":"crossref","first-page":"e31099","DOI":"10.1002\/pbc.31099","article-title":"BRAF-V600E mutations in plasma and peripheral blood mononuclear cells correlate with prognosis of pediatric Langerhans cell histiocytosis treated with first-line therapy","volume":"71","author":"Wang","year":"2024","journal-title":"Pediatr Blood Cancer"},{"issue":"4","key":"10.1016\/j.path.2024.11.001_bib21","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1182\/bloodadvances.2019032367","article-title":"High-risk LCH in infants is serially transplantable in a xenograft model but responds durably to targeted therapy","volume":"4","author":"Lee","year":"2020","journal-title":"Blood Adv"},{"issue":"3","key":"10.1016\/j.path.2024.11.001_bib22","doi-asserted-by":"crossref","first-page":"e97","DOI":"10.3324\/haematol.2018.201194","article-title":"Highly sensitive methods are required to detect mutations in histiocytoses","volume":"104","author":"Melloul","year":"2019","journal-title":"Haematologica"},{"issue":"1","key":"10.1016\/j.path.2024.11.001_bib23","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1002\/hon.2388","article-title":"The use of BRAF V600E mutation-specific immunohistochemistry in pediatric Langerhans cell histiocytosis","volume":"36","author":"Ballester","year":"2018","journal-title":"Hematol Oncol"},{"issue":"10","key":"10.1016\/j.path.2024.11.001_bib24","doi-asserted-by":"crossref","first-page":"1390","DOI":"10.1097\/PAS.0000000000000897","article-title":"Cyclin D1 is expressed in neoplastic cells of langerhans cell histiocytosis but not reactive langerhans cell proliferations","volume":"41","author":"Shanmugam","year":"2017","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.path.2024.11.001_bib25","series-title":"Histiocytic disorders","first-page":"3","article-title":"Pathology of histiocytic disorders and neoplasms and related disorders","author":"Picarsic","year":"2018"},{"issue":"19","key":"10.1016\/j.path.2024.11.001_bib26","doi-asserted-by":"crossref","first-page":"2188","DOI":"10.1182\/blood.2020005209","article-title":"Bone marrow-derived myeloid progenitors as driver mutation carriers in high- and low-risk Langerhans cell histiocytosis","volume":"136","author":"Xiao","year":"2020","journal-title":"Blood"},{"issue":"11","key":"10.1016\/j.path.2024.11.001_bib27","doi-asserted-by":"crossref","first-page":"3057","DOI":"10.1007\/s00381-023-06108-7","article-title":"Langerhans cell histiocytosis with aneurysmal bone cyst-like changes: a case-based literature review","volume":"39","author":"Mo","year":"2023","journal-title":"Child's Nerv Syst"},{"issue":"Pt 4","key":"10.1016\/j.path.2024.11.001_bib28","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1093\/brain\/awh403","article-title":"Neuropathology of CNS disease in Langerhans cell histiocytosis","volume":"128","author":"Grois","year":"2005","journal-title":"Brain"},{"issue":"12","key":"10.1016\/j.path.2024.11.001_bib29","doi-asserted-by":"crossref","first-page":"2607","DOI":"10.1002\/cncr.31348","article-title":"CNS Langerhans cell histiocytosis: common hematopoietic origin for LCH-associated neurodegeneration and mass lesions","volume":"124","author":"McClain","year":"2018","journal-title":"Cancer"},{"issue":"5","key":"10.1016\/j.path.2024.11.001_bib30","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1038\/s41591-021-01304-x","article-title":"BRAF(V600E)-induced senescence drives Langerhans cell histiocytosis pathophysiology","volume":"27","author":"Bigenwald","year":"2021","journal-title":"Nat Med"},{"issue":"10","key":"10.1016\/j.path.2024.11.001_bib31","first-page":"10.561744","article-title":"Circulating senescent myeloid cells drive blood brain barrier breakdown and neurodegeneration","volume":"2023","author":"Wilk","year":"2023","journal-title":"bioRxiv"},{"issue":"7","key":"10.1016\/j.path.2024.11.001_bib32","doi-asserted-by":"crossref","first-page":"e29115","DOI":"10.1002\/pbc.29115","article-title":"High prevalence of BRAF(V600E) in patients with cholestasis, sclerosing cholangitis or liver fibrosis secondary to Langerhans cell histiocytosis","volume":"68","author":"Carrere","year":"2021","journal-title":"Pediatr Blood Cancer"},{"issue":"5","key":"10.1016\/j.path.2024.11.001_bib33","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1016\/j.hoc.2015.06.001","article-title":"Nosology and pathology of langerhans cell histiocytosis","volume":"29","author":"Picarsic","year":"2015","journal-title":"Hematol Oncol Clin North Am"},{"issue":"6\u20137","key":"10.1016\/j.path.2024.11.001_bib34","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1016\/j.clinre.2011.03.012","article-title":"Langerhans' cell histiocytosis of the liver in adults","volume":"35","author":"Abdallah","year":"2011","journal-title":"Clin Res Hepatol Gastroenterol"},{"issue":"3","key":"10.1016\/j.path.2024.11.001_bib35","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1007\/s10024-003-9876-z","article-title":"Liver involvement in the histiocytic disorders of childhood","volume":"7","author":"Jaffe","year":"2004","journal-title":"Pediatr Dev Pathol"},{"issue":"4","key":"10.1016\/j.path.2024.11.001_bib36","first-page":"370","article-title":"Liver involvement in Langerhans' cell histiocytosis: a study of nine cases","volume":"12","author":"Kaplan","year":"1999","journal-title":"Mod Pathol"},{"issue":"2","key":"10.1016\/j.path.2024.11.001_bib37","doi-asserted-by":"crossref","first-page":"101","DOI":"10.2350\/09-05-0651-OA.1","article-title":"Bone marrow findings at diagnosis in patients with multisystem langerhans cell histiocytosis","volume":"13","author":"Galluzzo","year":"2010","journal-title":"Pediatr Dev Pathol"},{"issue":"2","key":"10.1016\/j.path.2024.11.001_bib38","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1182\/blood-2016-12-757823","article-title":"Hematopoietic origin of Langerhans cell histiocytosis and Erdheim Chester disease in adults","volume":"130","author":"Milne","year":"2017","journal-title":"Blood"},{"issue":"S1","key":"10.1016\/j.path.2024.11.001_bib39","doi-asserted-by":"crossref","first-page":"e30097","DOI":"10.1002\/pbc.30097","volume":"70","year":"2023","journal-title":"Pediatr Blood Cancer"},{"issue":"7","key":"10.1016\/j.path.2024.11.001_bib40","doi-asserted-by":"crossref","first-page":"991","DOI":"10.1182\/blood-2014-06-581736","article-title":"A common progenitor cell in LCH and ECD","volume":"124","author":"Badalian-Very","year":"2014","journal-title":"Blood"},{"issue":"7","key":"10.1016\/j.path.2024.11.001_bib41","doi-asserted-by":"crossref","first-page":"1119","DOI":"10.1182\/blood-2013-12-543793","article-title":"Association of both Langerhans cell histiocytosis and Erdheim-Chester disease linked to the BRAFV600E mutation: a multicenter study of 23 cases","volume":"124","author":"Hervier","year":"2014","journal-title":"Blood"},{"issue":"13","key":"10.1016\/j.path.2024.11.001_bib42","doi-asserted-by":"crossref","first-page":"1167","DOI":"10.1182\/blood.2023020569","article-title":"Childhood-onset Erdheim-Chester disease in the molecular era: clinical phenotypes and long-term outcomes of 21 patients","volume":"142","author":"Pegoraro","year":"2023","journal-title":"Blood"},{"issue":"1","key":"10.1016\/j.path.2024.11.001_bib43","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1186\/s40478-019-0811-6","article-title":"BRAF V600E mutation in Juvenile Xanthogranuloma family neoplasms of the central nervous system (CNS-JXG): a revised diagnostic algorithm to include pediatric Erdheim-Chester disease","volume":"7","author":"Picarsic","year":"2019","journal-title":"Acta Neuropathol Commun"},{"issue":"1","key":"10.1016\/j.path.2024.11.001_bib44","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1084\/jem.20161881","article-title":"RAF\/MEK\/extracellular signal-related kinase pathway suppresses dendritic cell migration and traps dendritic cells in Langerhans cell histiocytosis lesions","volume":"215","author":"Hogstad","year":"2018","journal-title":"J Exp Med"},{"key":"10.1016\/j.path.2024.11.001_bib45","series-title":"Histiocytic disorders","first-page":"293","article-title":"Juvenile xanthogranuloma and related non-LCH disorders","author":"Ceppi","year":"2018"},{"issue":"1","key":"10.1016\/j.path.2024.11.001_bib46","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1097\/01.pas.0000147395.01229.06","article-title":"Juvenile xanthogranuloma in childhood and adolescence: a clinicopathologic study of 129 patients from the kiel pediatric tumor registry","volume":"29","author":"Janssen","year":"2005","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.path.2024.11.001_bib47","series-title":"WHO classification of tumours editorial board. Haematolymphoid tumours","article-title":"Juvenile xanthogranuloma","author":"Alaggio","year":"2024"},{"key":"10.1016\/j.path.2024.11.001_bib48","series-title":"Histiocytic disorders","first-page":"3","article-title":"Pathology of histiocytic disorders and neoplasms and related disorders","author":"Picarsic","year":"2018"},{"issue":"5","key":"10.1016\/j.path.2024.11.001_bib49","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1097\/00000372-199610000-00008","article-title":"Non-Langerhans cell histiocytoses. A new unifying concept","volume":"18","author":"Zelger","year":"1996","journal-title":"Am J Dermatopathol"},{"key":"10.1016\/j.path.2024.11.001_bib50","series-title":"S100 immunohistochemistry in 65 localized juvenile xanthogranuloma family lesions: understanding staining patterns with clinicopathologic correlation. Spring 2017 meeting of the society for pediatric pathology","year":"2017"},{"issue":"2","key":"10.1016\/j.path.2024.11.001_bib51","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1182\/blood.2021013338","article-title":"ALK-positive histiocytosis: a new clinicopathologic spectrum highlighting neurologic involvement and responses to ALK inhibition","volume":"139","author":"Kemps","year":"2022","journal-title":"Blood"},{"issue":"12","key":"10.1016\/j.path.2024.11.001_bib52","doi-asserted-by":"crossref","first-page":"1839","DOI":"10.1038\/s41591-019-0653-6","article-title":"Activating mutations in CSF1R and additional receptor tyrosine kinases in histiocytic neoplasms","volume":"25","author":"Durham","year":"2019","journal-title":"Nat Med"},{"issue":"11","key":"10.1016\/j.path.2024.11.001_bib53","doi-asserted-by":"crossref","first-page":"991","DOI":"10.1111\/cup.14510","article-title":"NTRK expression is common in xanthogranuloma and is associated with the solitary variant","volume":"50","author":"Umphress","year":"2023","journal-title":"J Cutan Pathol"},{"issue":"S7","key":"10.1016\/j.path.2024.11.001_bib54","doi-asserted-by":"crossref","first-page":"e30714","DOI":"10.1002\/pbc.30714","volume":"70","year":"2023","journal-title":"Pediatr Blood Cancer"},{"issue":"28","key":"10.1016\/j.path.2024.11.001_bib55","doi-asserted-by":"crossref","first-page":"46065","DOI":"10.18632\/oncotarget.17521","article-title":"Activating MAPK1 (ERK2) mutation in an aggressive case of disseminated juvenile xanthogranuloma","volume":"8","author":"Chakraborty","year":"2017","journal-title":"Oncotarget"},{"issue":"13","key":"10.1016\/j.path.2024.11.001_bib56","doi-asserted-by":"crossref","first-page":"2991","DOI":"10.1182\/bloodadvances.2020001890","article-title":"Dasatinib induces a dramatic response in a child with refractory juvenile xanthogranuloma with a novel MRC1-PDGFRB fusion","volume":"4","author":"Eissa","year":"2020","journal-title":"Blood Adv"},{"issue":"22","key":"10.1016\/j.path.2024.11.001_bib57","doi-asserted-by":"crossref","first-page":"2672","DOI":"10.1182\/blood-2016-01-690636","article-title":"Revised classification of histiocytoses and neoplasms of the macrophage-dendritic cell lineages","volume":"127","author":"Emile","year":"2016","journal-title":"Blood"},{"key":"10.1016\/j.path.2024.11.001_bib58","series-title":"WHO classification of tumours editorial board. Haematolymphoid tumours","article-title":"ALK-positive histiocytosis","author":"Chan","year":"2024"},{"issue":"7","key":"10.1016\/j.path.2024.11.001_bib59","doi-asserted-by":"crossref","first-page":"2965","DOI":"10.1182\/blood-2008-03-147017","article-title":"ALK+ histiocytosis: a novel type of systemic histiocytic proliferative disorder of early infancy","volume":"112","author":"Chan","year":"2008","journal-title":"Blood"},{"issue":"5","key":"10.1016\/j.path.2024.11.001_bib60","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1177\/1093526617740784","article-title":"Expanding the phenotype of ALK-positive histiocytosis: a report of 2 cases","volume":"21","author":"Huang","year":"2018","journal-title":"Pediatr Dev Pathol"},{"issue":"5","key":"10.1016\/j.path.2024.11.001_bib61","doi-asserted-by":"crossref","first-page":"598","DOI":"10.1038\/s41379-018-0168-6","article-title":"ALK-positive histiocytosis: an expanded clinicopathologic spectrum and frequent presence of KIF5B-ALK fusion","volume":"32","author":"Chang","year":"2019","journal-title":"Mod Pathol"},{"issue":"6","key":"10.1016\/j.path.2024.11.001_bib62","doi-asserted-by":"crossref","first-page":"786","DOI":"10.1097\/PAS.0000000000000611","article-title":"Primary and metastatic cutaneous melanomas express ALK through alternative transcriptional initiation","volume":"40","author":"Busam","year":"2016","journal-title":"Am J Surg Pathol"},{"issue":"26","key":"10.1016\/j.path.2024.11.001_bib64","doi-asserted-by":"crossref","first-page":"2877","DOI":"10.1182\/blood-2018-03-839753","article-title":"Consensus recommendations for the diagnosis and clinical management of Rosai-Dorfman-Destombes disease","volume":"131","author":"Abla","year":"2018","journal-title":"Blood"},{"key":"10.1016\/j.path.2024.11.001_bib65","series-title":"WHO classification of tumours editorial board. Haematolymphoid tumours","article-title":"Rosai-Dorfman disease","author":"Natkunam","year":"2024"},{"key":"10.1016\/j.path.2024.11.001_bib66","series-title":"Pathology of histiocytic disorders and neoplasms and related disorders","first-page":"339","author":"Abla","year":"2017"},{"issue":"2","key":"10.1016\/j.path.2024.11.001_bib67","doi-asserted-by":"crossref","first-page":"e1000833","DOI":"10.1371\/journal.pgen.1000833","article-title":"Mutations in SLC29A3, encoding an equilibrative nucleoside transporter ENT3, cause a familial histiocytosis syndrome (Faisalabad histiocytosis) and familial Rosai-Dorfman disease","volume":"6","author":"Morgan","year":"2010","journal-title":"PLoS Genet"},{"key":"10.1016\/j.path.2024.11.001_bib68","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1111\/cup.13285","article-title":"Emperipolesis and S100 expression may be seen in cutaneous xanthogranulomas: a multi-institutional observation","volume":"45","author":"Ruby","year":"2018","journal-title":"J Cutan Pathol"},{"issue":"6","key":"10.1016\/j.path.2024.11.001_bib69","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1111\/bjh.16006","article-title":"Cyclin D1 expression and novel mutational findings in Rosai-Dorfman disease","volume":"186","author":"Baraban","year":"2019","journal-title":"Br J Haematol"},{"issue":"12","key":"10.1016\/j.path.2024.11.001_bib70","doi-asserted-by":"crossref","first-page":"1848","DOI":"10.1182\/bloodadvances.2019000093","article-title":"BRAF-V600E-mutated Rosai-Dorfman-Destombes disease and Langerhans cell histiocytosis with response to BRAF inhibitor","volume":"3","author":"Mastropolo","year":"2019","journal-title":"Blood Adv"},{"issue":"1","key":"10.1016\/j.path.2024.11.001_bib71","doi-asserted-by":"crossref","first-page":"e5","DOI":"10.3324\/haematol.2019.216937","article-title":"Erdheim-Chester disease with concomitant Rosai-Dorfman like lesions: a distinct entity mainly driven by MAP2K1","volume":"105","author":"Razanamahery","year":"2020","journal-title":"Haematologica"},{"issue":"2","key":"10.1016\/j.path.2024.11.001_bib72","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1182\/blood-2016-12-757377","article-title":"Functional evidence for derivation of systemic histiocytic neoplasms from hematopoietic stem\/progenitor cells","volume":"130","author":"Durham","year":"2017","journal-title":"Blood"},{"issue":"10","key":"10.1016\/j.path.2024.11.001_bib73","doi-asserted-by":"crossref","first-page":"100268","DOI":"10.1016\/j.modpat.2023.100268","article-title":"Malignant histiocytosis comprises a phenotypic spectrum that parallels the lineage differentiation of monocytes, macrophages, dendritic cells, and langerhans cells","volume":"36","author":"Ravindran","year":"2023","journal-title":"Mod Pathol"},{"issue":"5","key":"10.1016\/j.path.2024.11.001_bib74","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1002\/ajh.27263","article-title":"Clinical characteristics, molecular aberrations, treatments, and outcomes of malignant histiocytosis","volume":"99","author":"Ruan","year":"2024","journal-title":"Am J Hematol"},{"issue":"3","key":"10.1016\/j.path.2024.11.001_bib75","doi-asserted-by":"crossref","first-page":"225","DOI":"10.2350\/09-03-0622-OA.1","article-title":"Clinicopathologic features of histiocytic lesions following ALL, with a review of the literature","volume":"13","author":"Castro","year":"2010","journal-title":"Pediatr Dev Pathol"}],"container-title":["Surgical Pathology Clinics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1875918124000850?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1875918124000850?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,5,22]],"date-time":"2025-05-22T15:36:22Z","timestamp":1747928182000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1875918124000850"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6]]},"references-count":74,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2025,6]]}},"alternative-id":["S1875918124000850"],"URL":"https:\/\/doi.org\/10.1016\/j.path.2024.11.001","relation":{},"ISSN":["1875-9181"],"issn-type":[{"value":"1875-9181","type":"print"}],"subject":[],"published":{"date-parts":[[2025,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Pediatric Pathology","name":"articletitle","label":"Article Title"},{"value":"Surgical Pathology Clinics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.path.2024.11.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}